172 related articles for article (PubMed ID: 14500342)
1. Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors.
Forbes NS; Munn LL; Fukumura D; Jain RK
Cancer Res; 2003 Sep; 63(17):5188-93. PubMed ID: 14500342
[TBL] [Abstract][Full Text] [Related]
2. Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro.
Kasinskas RW; Forbes NS
Biotechnol Bioeng; 2006 Jul; 94(4):710-21. PubMed ID: 16470601
[TBL] [Abstract][Full Text] [Related]
3. Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis.
Kasinskas RW; Forbes NS
Cancer Res; 2007 Apr; 67(7):3201-9. PubMed ID: 17409428
[TBL] [Abstract][Full Text] [Related]
4. Containment of tumor-colonizing bacteria by host neutrophils.
Westphal K; Leschner S; Jablonska J; Loessner H; Weiss S
Cancer Res; 2008 Apr; 68(8):2952-60. PubMed ID: 18413765
[TBL] [Abstract][Full Text] [Related]
5. In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis.
Ganai S; Arenas RB; Sauer JP; Bentley B; Forbes NS
Cancer Gene Ther; 2011 Jul; 18(7):457-66. PubMed ID: 21436868
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic control of tumor-colonizing Salmonella enterica serovar Typhimurium.
Crull K; Weiss S
Exp Biol Med (Maywood); 2011 Nov; 236(11):1282-90. PubMed ID: 21987828
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
Hoffman RM
Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
[TBL] [Abstract][Full Text] [Related]
8. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer.
Zhao M; Geller J; Ma H; Yang M; Penman S; Hoffman RM
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10170-4. PubMed ID: 17548809
[TBL] [Abstract][Full Text] [Related]
9. Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium.
Crull K; Bumann D; Weiss S
FEMS Immunol Med Microbiol; 2011 Jun; 62(1):75-83. PubMed ID: 21314734
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.
Zhao M; Yang M; Ma H; Li X; Tan X; Li S; Yang Z; Hoffman RM
Cancer Res; 2006 Aug; 66(15):7647-52. PubMed ID: 16885365
[TBL] [Abstract][Full Text] [Related]
11. Attenuated Salmonella enterica Typhimurium reduces tumor burden in an autochthonous breast cancer model.
Drees J; Mertensotto M; Liu G; Panyam J; Leonard A; Augustin L; Schottel J; Saltzman D
Anticancer Res; 2015 Feb; 35(2):843-9. PubMed ID: 25667465
[TBL] [Abstract][Full Text] [Related]
12. Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy.
Phan TX; Nguyen VH; Duong MT; Hong Y; Choy HE; Min JJ
Microbiol Immunol; 2015 Nov; 59(11):664-75. PubMed ID: 26500022
[TBL] [Abstract][Full Text] [Related]
13. High-efficacy targeting of colon-cancer liver metastasis with Salmonella typhimurium A1-R via intra-portal-vein injection in orthotopic nude-mouse models.
Kawaguchi K; Murakami T; Suetsugu A; Kiyuna T; Igarashi K; Hiroshima Y; Zhao M; Zhang Y; Bouvet M; Clary BM; Unno M; Hoffman RM
Oncotarget; 2017 Mar; 8(12):19065-19073. PubMed ID: 27683127
[TBL] [Abstract][Full Text] [Related]
14. Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.
Kocijancic D; Felgner S; Schauer T; Frahm M; Heise U; Zimmermann K; Erhardt M; Weiss S
Oncotarget; 2017 Jul; 8(30):49988-50001. PubMed ID: 28637010
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
[TBL] [Abstract][Full Text] [Related]
16. Methods for Tumor Targeting with Salmonella typhimurium A1-R.
Hoffman RM; Zhao M
Methods Mol Biol; 2016; 1409():143-64. PubMed ID: 26846809
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R.
Miwa S; Zhang Y; Baek KE; Uehara F; Yano S; Yamamoto M; Hiroshima Y; Matsumoto Y; Kimura H; Hayashi K; Yamamoto N; Bouvet M; Tsuchiya H; Hoffman RM; Zhao M
Oncotarget; 2014 Dec; 5(24):12849-61. PubMed ID: 25528763
[TBL] [Abstract][Full Text] [Related]
18. Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek JM; Low KB; Bermudes D
Cancer Res; 1997 Oct; 57(20):4537-44. PubMed ID: 9377566
[TBL] [Abstract][Full Text] [Related]
19. Salmonella-typhimurium-specific difference in rate of intracellular killing by resident peritoneal macrophages from salmonella-resistant CBA and salmonella-susceptible C57BL/10 mice.
van Dissel JT; Stikkelbroeck JJ; Michel BC; Leijh PC; van Furth R
J Immunol; 1987 Jun; 138(12):4428-34. PubMed ID: 3295047
[TBL] [Abstract][Full Text] [Related]
20. An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
Chou CK; Hung JY; Liu JC; Chen CT; Hung MC
Cancer Gene Ther; 2006 Aug; 13(8):746-52. PubMed ID: 16410824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
